Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-19-013125
Filing Date
2019-07-18
Accepted
2019-07-18 16:12:53
Documents
7
Period of Report
2019-07-18

Document Format Files

Seq Description Document Type Size
1 6-K form6k.htm 6-K 10492
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 31249
3 image00006.jpg GRAPHIC 3311
4 image00010.jpg GRAPHIC 26676
5 image00011.jpg GRAPHIC 25181
6 image00012.jpg GRAPHIC 21846
7 image00013.jpg GRAPHIC 26630
  Complete submission text file 0001140361-19-013125.txt   186089
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 19961440
SIC: 2834 Pharmaceutical Preparations